4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-23-053817
Options or other derivatives
- General Counsel and Secretary acquired 23,007 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2023-10-13 | Grant or award · Stock Option (Right to Buy) | +16,667 | 16,667 | D: show line 1 in the form | |||||
| KASINGER JAMES R. General Counsel and Secretary | 2023-10-13 | Grant or award · Restricted Stock Units | +6,340 | 6,340 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…